Veerhealth Care Limited (BOM:511523)
India
· Delayed Price · Currency is INR 19.92
+0.17 (0.86%)
At close: Mar 10, 2026
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 213.43 | 166.71 | 132.23 | 132.73 | 96.26 | 105.8 | Upgrade
|
| Other Revenue | 4.03 | 6.13 | 9.9 | 9.41 | 11.73 | 7.9 | Upgrade
|
| Revenue | 217.46 | 172.84 | 142.13 | 142.14 | 107.99 | 113.7 | Upgrade
|
| Revenue Growth (YoY) | 45.15% | 21.60% | -0.00% | 31.62% | -5.02% | -3.23% | Upgrade
|
| Cost of Revenue | 147.13 | 115.83 | 92.56 | 94.75 | 71.27 | 75.16 | Upgrade
|
| Gross Profit | 70.33 | 57.01 | 49.57 | 47.39 | 36.73 | 38.54 | Upgrade
|
| Selling, General & Admin | 17.32 | 17.04 | 15.38 | 12.87 | 11.79 | 8.28 | Upgrade
|
| Other Operating Expenses | 33.33 | 29.22 | 18.2 | 20.14 | 21.41 | 21.7 | Upgrade
|
| Operating Expenses | 62.74 | 55.34 | 40.69 | 39.22 | 38.44 | 34.65 | Upgrade
|
| Operating Income | 7.59 | 1.66 | 8.88 | 8.17 | -1.72 | 3.89 | Upgrade
|
| Interest Expense | -2.64 | -0.96 | - | - | -0.45 | -2.11 | Upgrade
|
| Interest & Investment Income | 6.05 | 6.05 | 3.99 | 2.99 | 4.94 | 4.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.68 | -1.68 | -0.08 | -0.01 | -0.41 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | 9.33 | 5.08 | 12.8 | 11.14 | 2.38 | 5.77 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.03 | - | - | Upgrade
|
| Pretax Income | 9.33 | 5.08 | 12.82 | 11.17 | 2.38 | 5.77 | Upgrade
|
| Income Tax Expense | 1.46 | 1.16 | 8.75 | -4.65 | 3.11 | 1.98 | Upgrade
|
| Net Income | 7.86 | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 | Upgrade
|
| Net Income to Common | 7.86 | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 | Upgrade
|
| Net Income Growth | - | -3.62% | -74.33% | - | - | 19.13% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 1.23% | - | - | 44.20% | - | 0.00% | Upgrade
|
| EPS (Basic) | 0.40 | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 | Upgrade
|
| EPS (Diluted) | 0.40 | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 | Upgrade
|
| EPS Growth | - | -3.62% | -74.33% | - | - | 19.13% | Upgrade
|
| Free Cash Flow | - | -92.02 | 20.7 | -27.85 | 2.25 | 5.06 | Upgrade
|
| Free Cash Flow Per Share | - | -4.60 | 1.03 | -1.39 | 0.16 | 0.36 | Upgrade
|
| Gross Margin | 32.34% | 32.98% | 34.88% | 33.34% | 34.01% | 33.89% | Upgrade
|
| Operating Margin | 3.49% | 0.96% | 6.25% | 5.75% | -1.59% | 3.42% | Upgrade
|
| Profit Margin | 3.62% | 2.27% | 2.86% | 11.13% | -0.68% | 3.33% | Upgrade
|
| Free Cash Flow Margin | - | -53.24% | 14.56% | -19.59% | 2.08% | 4.45% | Upgrade
|
| EBITDA | 18.14 | 10.74 | 16 | 14.39 | 3.53 | 8.57 | Upgrade
|
| EBITDA Margin | 8.34% | 6.21% | 11.25% | 10.12% | 3.26% | 7.54% | Upgrade
|
| D&A For EBITDA | 10.55 | 9.08 | 7.12 | 6.22 | 5.24 | 4.68 | Upgrade
|
| EBIT | 7.59 | 1.66 | 8.88 | 8.17 | -1.72 | 3.89 | Upgrade
|
| EBIT Margin | 3.49% | 0.96% | 6.25% | 5.75% | -1.59% | 3.42% | Upgrade
|
| Effective Tax Rate | 15.70% | 22.92% | 68.31% | - | 130.98% | 34.25% | Upgrade
|
| Revenue as Reported | 223.51 | 178.89 | 146.13 | 145.13 | 112.94 | 117.77 | Upgrade
|
| Advertising Expenses | - | 1.26 | 2.28 | 3.67 | 2.92 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.